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A B S T R A C T
Background: The percutaneous transvenous mitral commissurotomy is an important procedure for the
treatment of mitral stenosis. A lot of mitral stenosis cases have left atrial appendage clot which precludes
the patient from the beneﬁt of this procedure.
The aim of the study was to study the feasibility and safety of the procedure in a patient with
appendage clot in the setup of certain urgent conditions.
Method: All cases of mitral stenosis with signiﬁcant dyspnea and mitral valve area <1.5 cm2 with left
atrial appendage clot and a condition which would preclude the patient from continuing on
anticoagulation and needed urgent intervention were included in the study. From January 2011 to
December 2013, twenty patients coming to Shahid Gangalal National Heart Centre, Kathmandu were
selected for the procedure with conventional sampling technique. Informed written consent was
obtained from the patients explaining all possible complications. The approval of the study was taken
from the ethical committee of the hospital.
Result: Mean mitral valve area increased from 0.90 cm2 (SD  0.14) to 1.5 cm2 (SD  0.21) (p = 0.02). Left
atrial mean pressure decreased from mean of 20 to 10 mmHg. Subjective improvement was reported in all.
All of the patients had fulﬁlled criteria for successful PTMC. There was no mortality during hospital stay or in
one-week follow-up period. There were no neurological complications or any need for emergency surgery.
Conclusion: The immediate result of percutaneous transvenous mitral commissurotomy in selected
cases of mitral stenosis with left atrial appendage clot is safe and acceptable in certain urgent situations
in experienced hands.
 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The incidence of rheumatic heart disease has not declined in
our region. About one-third of admissions to our hospital is due to
rheumatic heart disease; among them, one-third consist of
isolated mitral stenosis. The treatment of choice in this situation
is percutaneous transvenous mitral commissurotomy (PTMC).1–3
Since the beginning of interventional program in our hospital
about 15 years back, all suitable cases of mitral stenosis without* Corresponding author. Tel.: +977 9851052350; fax: +977 14371123.
E-mail address: rajibrbhandari@yahoo.com (R. Rajbhandari).
http://dx.doi.org/10.1016/j.ihj.2016.04.020
0019-4832/ 2016 Published by Elsevier B.V. on behalf of Cardiological Society of
creativecommons.org/licenses/by-nc-nd/4.0/).left atrial clot are taken for PTMC. But left atrial (LA) clot is present
in nearly 15% of severe mitral stenosis according to hospital
registry; 90% of them are inside LA appendage and only 10% are
placed in the left atrial body. Medical literature consider PTMC to
be risky in the presence of the clot, and this precludes many
patients from the beneﬁt of this procedure. Thus LA appendage
clot is considered as contra-indication to PTMC in standard
practice and usually treated medically with anticoagulation or
referred for surgery. But in some conditions, either mode of
treatment may not be appropriate. The present study aimed to
evaluate the feasibility and safety of PTMC procedure in a patient
with LA appendage clot in emergency situation or when no other
reasonable option is available. This is a ﬁrst study of this kind in
our region. India. This is an open access article under the CC BY-NC-ND license (http://
Fig. 1. Transesophageal echo showing a clot lying well inside the LA appendage.
Table 1
Few important echo parameters of patients.
LA size in mm 43 (3.3)
LA pressure mmHg pre procedure 20 (2.7)
LA pressure mmHg Post procedure 10 (1.2)
MVA pre procedure cm2 0.9 (0.14)
MVA post procedure cm2 1.5 (0.21)
LV ejection fraction % 53 (4)
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All cases of mitral stenosis attending our hospital with
signiﬁcant symptoms of dyspnea, NYHA class II or more and
mitral valve area (MVA) < 1.5 cm2 with left atrial (LA) appendage
clot (Type Ia) - mitral stenosis patients with LA appendage clot
not protruding out of LA appendage and any of the following:
pregnancy, or patient in pulmonary edema, or patients who
recently had bleeding disorder or patient with stroke, or patients
whose clot did not get dissolved despite adequate anticoagula-
tion with warfarin for more than nine months and still
had signiﬁcant symptoms or those who were unable to go for
surgery.
Exclusion criteria were left atrial body thrombus, LA appendage
clot extending into LA, mitral regurgitation with >3 grade,
bicommissural calciﬁcation or severe grade 4 calciﬁcation, and
severe aortic valve disease. From January 2011 to December 2013,
twenty patients were selected for the procedure. Echo was done to
diagnose and classify the mitral valve according to Wilkins scoring
system. Routine investigations were performed which included
total leukocyte count, differential count, hemoglobin, X-ray chest,
ECG, and serum urea, creatinine, sodium and potassium. Trans-
thoracic and trans-esophageal echocardiography was performed to
observe for LA and LA appendage clot. GE Vivid S6 pediatric (TEE)
and adult (TTE) probe was used for the purpose. Right femoral
artery and right femoral vein was accessed with 5 and 8 French
sheath. Pigtail catheters in non-coronary cusp of ascending aorta
served as land mark.4–7 Puncturing of inter-atrial septum was done
through right femoral vein by MulLins sheath and Brokenborough
needle.
Once the inter-atrial septum was punctured and MulLins
sheath entered, the LA appendage was outlined with injection of
contrast material. This gave a good idea of the appendage area
which was to be avoided during balloon manipulation. Special
precaution was taken not to bring the coiled wire and balloon tip
above the level of LA appendage. While entering the balloon into
the LA through the coiled wire, the wire was kept low inside LA and
the balloon was pushed slowly into LA to make a complete circle.
This kept the balloon tip away from disturbing LA appendage. The
reverse loop technique (balloon encircling the whole of LA in
anticlockwise direction) was avoided to keep the balloon tip away
from the LA appendage. Firm J wire was used instead of ﬂexible J
wire. This avoided unnecessary movement of the balloon tip.
Mitral valve was dilated only once with the maximum permissible
size (that is height in cm divided by ten plus ten), instead of
stepwise repeated dilatation. Inoue balloon was used for the
purpose. Three thousand units of un-fractionated heparin was
administered during the procedure.
In pregnant ladies, the fetus was protected from radiation with
pelvic and abdominal shields. The lead gown was put beneath the
back extending from lower part of thorax to the buttock. Neck-
guard shields were put on their abdomen. Check echocardiogram
was done the next day. Successful PTMC were considered as those
with ﬁnal MVA  1.5 cm2 or who had doubling of MVA after the
procedure.8,9 Most patients were discharged the next day except
those who had presented with pulmonary edema. Discharged
patients were followed up in clinic after a week.
Fig. 1, shows a typical case with a small clot inside LA
appendage.
3. Results
Age of the patients ranged from 20 years to 58 years. Mean age
of the patient was 31.4  9.3 years, mean height was 157.5  4.3 cm,
and mean weight was 54.6  3.9 kg. Male to female ratio was 0.35 : 1.
Patients were of different clinical background. Out of 20 patients, (a)3 ladies were pregnant and were not on anticoagulants because of the
risk to the fetus, (b) 2 patients were in frank pulmonary edema; TEE
could not be done on them; instead left atrial appendage clots were
detected on transthoracic echo, these patients had to undergo the
procedure as a rescue procedure, (c) 9 patients had received warfarin
therapy for more than 12 months with adequate INR levels and had
class III symptoms, (d) 2 had attended hospital ER with suprather-
apeutic INR and still had clot despite prolonged warfarin therapy for
more than 12 months, (e) 3 were in NYHA class III-IV despite
medication and were attending ER in heart failure frequently, and (f)
one had recent history of embolic stroke with hemorrhagic
complication and NYHA class III symptoms (Table 1).
Forty percent of the study patients were in atrial ﬁbrillation.
Mean MVA increased from 0.90 cm2 (SD + 0.14) to 1.5 cm2
(SD + 0.21) (p = 0.02). Minimum pre-procedure and maximum
post-procedure MVA was 0.5 cm2 and 2.0 cm2 respectively.
Repeat echo at 3 months could not be done in majority of the
patients because of poor follow-up. Left atrial mean pressure
decreased from mean of 20 to 10 mmHg. Subjective improve-
ment was reported in all 20 patients. All had fulﬁlled criteria for
successful PTMC. There was no mortality during hospital stay
and in one-week follow-up. Five patients had mild MR and one
had moderate MR. No one had cardiac tamponade or severe
mitral regurgitation unlike other major studies.10,11 None died
during the procedure or due to complication from the procedure.
None had any neurological complications or stroke. There was
no need for emergency surgery in any of the cases. One of these
patients developed atrial ﬁbrillation with fast ventricular
response with hemodynamic compromise which settled on its
own (Fig. 2).
4. Discussion
PTMC procedure is provided free of cost in our government
hospitals while mitral valve replacement is a costly procedure.
Fig. 2. Inoue balloon being dilated in mitral valve.
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maintain INR after the valve replacement, especially those living in
remote hilly areas. Many of them fail to take medication and many
land up in ER with supratherapeutic INR and/or bleeding
complications. Thus whenever feasible PTMC is always a superior
option.
PTMC procedure can be sometimes difﬁcult and time
consuming in patients with dilated LA. Few injections of
contrast in LA and aorta to identify different landmarks make
the septal puncture safe and easy. This is helpful especially for
the operators who are not so experienced. Entry through patent
foramen ovale may not be the best site for puncture. This
approach makes left ventricle (LV) entry difﬁcult. Even other-
wise complex anatomy with large LA may make left ventricle
entry difﬁcult and time consuming. Consequently, with pro-
longed manipulations chances of thrombo-embolism increase.
Simple anatomy with relatively small LA and RA in our patients
in the study enabled the procedure to be performed smoothly
without thromboembolic complications. Using stiffer J-wire,
expert operators can maneuver balloon straight into LA without
disturbing the LA appendage area. In this study, the results in
terms of mitral valve area are less than optimal probably
because only one single dilatation of the balloon during the
procedure; no repeat dilatation was performed. Restriction to
single dilatation avoided unnecessary manipulation of the LA
appendage clot. If the landmarks are well delineated by contrast
injection into LA then one can easily avoid the areas of LA
appendage and hence not disturb the clot. A notable point IN
OUR STUDY was the fact that the most of the LA appendage clot
were probably organized since many patients had already taken
anticoagulation for a good period of time. Another notable point
among the patients in the study was 45% of the cases were in
atrial ﬁbrillation which is relatively high in comparison to an
other study.12 This could be because of the fact that the patient
population was somewhat older than in other studies.13–15 The
patient population in the study was special because there was
urgent need for relief of symptoms in these sick patients.
Although LA appendage clot is a relative contra-indication
for performance of PTMC there are no clear-0cut guidelines
in these sick patients with LA appendage clot. Furthermore,
this procedure has been described being done safely with orwithout carotid protection devices,16 but still it is not feasible in
many setups because of technical reasons and ﬁnancial
constraints of the patients. Despite the possibility of neurologi-
cal complications, the procedure has to be performed in high
risk.17 Our center by now has good experience of more than
6000 PTMC procedures with very minimal complication, low
mortality and negligible neurological complications. Refusing to
do PTMC sometimes means refusing any treatment for the
patient because there may be no other feasible or safe
alternative treatment for these patients. As described in our
study, few patients had been treated with anticoagulation for
more than one year but they had worsening of symptoms and
urgent treatment was the only alternative for their survival. The
patients with pulmonary edema had associated pneumonia
as well and were treated with antibiotics. The 3 pregnant
cases were on 7 months of conception and presented for the ﬁrst
time. The ﬂuoro exposure time among pregnant patients was
less than ﬁve minutes. In few other cases, the intervention could
not be delayed further because they were having symptoms.
Urgent mitral valve replacement is not technically easy in these
sicker patients and in addition there was a ﬁnancial constraint.
Thus, PTMC may be considered as a rescue procedure in
conditions like this where surgery is not feasible. Small patient
numbers is the major limitation of this study.
5. Conclusion
The immediate result of PTMC in selected cases of mitral
stenosis with LA appendage clot is acceptable in certain urgent
situations in experienced hands.18–20
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